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Summary
The PAR complex, consisting of the evolutionarily con-
served PAR-3, PAR-6, and aPKC, regulates cell polarity in
many cell types, including epithelial cells [1–4]. Consis-
tently, genetic manipulation of its components affects tissue
integrity in multiple biological systems [5–9]. However, the
regulatory mechanisms of the PAR complex remain obscure.
We report here that apoptosis-stimulating protein of p53
(ASPP2 or TP53BP2), which binds to the tumor suppressor
p53 and stimulates its proapoptotic function [10–12], posi-
tively regulates epithelial cell polarity by associating with
the PAR complex. ASPP2 interacts and colocalizes with
PAR-3 at apical cell-cell junctions in the polarized epithelial
cells. Depletion of ASPP2 in epithelial cells causes defects
in cell polarity, such as the formation of tight junctions and
the maintenance and development of apical membrane
domains. Moreover, depletion of ASPP2 causes a defect
in PAR-3 localization, as well as vice versa. Furthermore,
disturbance in the interaction between ASPP2 and PAR-3
causes defects in cell polarity. We conclude that ASPP2
regulates epithelial cell polarity in cooperation with PAR-3
to form an active PAR complex. Our results, taken together
with the known functions of ASPP2, suggest a close relation-
ship between cell polarity and other cell regulatory mecha-
nisms mediated by ASPP2.
Results and Discussion
Apoptosis-Stimulating Protein of p53 Physically
Associates with the PAR Complex
Almost all cells are polarized. Typical examples include epithe-
lial cells that show apicobasal polarity, neurons, and direction-
ally migrating cells [3, 4]. Cell polarity is also essential for the
asymmetric cell division required for the self-renewal of stem
and/or progenitor cells [13, 14]. Another example indicating
the importance of cell polarity is the epithelial-mesenchymal
transition, a step frequently seen in normal development and
in malignant transformation, which involves loss of cell-cell
adhesion and cell polarity [15, 16]. Thus, cell polarity is
one of the fundamental properties of cells, implicated not
only in the normal functioning of tissues but also in many
steps of tissue morphogenesis and malignant transformation.*Correspondence: ohnos@med.yokohama-cu.ac.jp
3These authors contributed equally to this workHowever, the relationship between the mechanisms regulating
cell polarity and other fundamental cell functions, especially
those that determine cell fate, such as growth and survival,
mostly remain to be clarified.
In mammalian epithelial cells, the PAR complex plays
a central role in the formation of tight junctions (TJs) and the
development of apical membrane domains in a process
that initiates epithelial polarization [3, 4, 17]. The formation of
the PAR complex is induced by the activation of Cdc42 and
the recruitment of PAR-3 to the primordial cell-cell contacts
[18, 19]. On the other hand, Lgl suppresses the formation of
the PAR complex by competing with PAR-3 for interaction
with the aPKC-PAR-6 complex [20]. To clarify the regulatory
mechanisms of PAR complex formation, we searched for
novel proteins interacting with PAR-3. We employed stable
lines of epithelial Madin-Darby canine kidney (MDCK) cells in
which endogenous PAR-3 was replaced by streptavidin-
binding peptide (SBP)-tagged PAR-3, and its expression
was controlled by doxycycline to the endogenous level (data
not shown). We analyzed the proteins specifically copurified
with SBP-tagged PAR-3 and sPAR-3, a short isoform of
PAR-3 [21] (see Figure S1A available online). The identified
proteins included the previously reported PAR-3-binding
proteins, such as atypical protein kinase Cl (aPKCl), PAR-6g,
and 14-3-3h. Furthermore, we identified apoptosis-stimulating
protein of p53 (ASPP2) as a novel PAR-3-specific binding
protein. The specific association between PAR-3 and ASPP2
was verified by cotransfection experiments in 293T cells
(Figure 1A).
ASPP2 has been identified as a binding partner of p53 that
mediates the apoptotic function of p53 by specifically stimu-
lating the expression of proapoptotic target genes [10–12].
However, the cellular role of ASPP2 in regulating epithelial
cell polarity remains to be clarified. We first raised, and
confirmed the specificity of, two anti-ASPP2 antibodies, C2
and C3, from different rabbits (Figure S1B). Immunoprecipita-
tion experiments using the C2 antibody revealed an endoge-
nous interaction between PAR-3 and ASPP2 in MDCK cells,
supporting the physiological importance of this interaction
(Figure 1B). ASPP2 immunoprecipitates also contained aPKCl
and PAR-6b (Figure 1B; see below). However, cotransfection
experiments in 293T cells demonstrated a significant interac-
tion of ASPP2 with PAR-3, but not with aPKCl or PAR-6b
(Figure S2A). We found that the N-terminal region of ASPP2
binds to the N- and C-terminal regions of PAR-3 (Figures
S2B–S2E). These results suggest that ASPP2 is a novel com-
ponent of the PAR complex associating via PAR-3. Because
the amounts of aPKCl coprecipitated with PAR-3 or ASPP2
were comparable (Figure 1B), and because Lgl2 did not copre-
cipitate with ASPP2 (see below), we assume that ASPP2 may
preferentially interact with PAR-3, which is associating with
aPKC; namely, ASPP2 may preferentially interact with active
PAR complexes [22].
ASPP2 Colocalizes with PAR-3 at Apical Cell-Cell
Junctions in Epithelial Cells and Tissues
One of the most important properties of the PAR complex is its
concentration at the apical cell-cell junctions in polarized
Figure 1. Protein Complex Formation and Colocalization of
ASPP2 with PAR-3 and aPKC
(A) 293T cells were transfected with the expression vectors
as indicated, and the cell lysates were subjected to immuno-
precipitation with anti-HA tag antibody. The cell lysates
(input, 0.2%) and coprecipitated proteins (IP, 50%) were
analyzed by western blot with anti-V5 tag, anti-HA tag, or
anti-aPKCz/l antibody.
(B) Madin-Darby canine kidney (MDCK) cells were subjected
to immunoprecipitation with anti-ASPP2 C2 antibody, anti-
PAR-3 antibody, or normal rabbit IgG as a control. Fractions
of cell lysates (input, 1%) and coprecipitated proteins (IP,
25%) were analyzed by anti-ASPP2 C3, anti-PAR-3, or anti-
aPKCl/i antibody.
(C) Nonsilencing control (NS) orASPP2-knockdown (ASPP2-
RNAi) stable MDCK clones were cultured on permeable
filters for 48 hr and coimmunostained for ASPP2 (C2; green)
and ZO-1 (magenta). The panels show representative single
confocal sections at the apical side.
(D) Western blot analysis of NS, PAR-3-RNAi, and ASPP2-
RNAi MDCK cells with antibodies against the indicated
proteins in both normal (NC) and low (LC) calcium culture
conditions. In either condition, the expression of PAR-3 or
ASPP2 was specifically reduced in PAR-3-RNAi or ASPP2-
RNAi MDCK cells, respectively. However, the expression of
other proteins was not markedly affected.
(E) Confluent MDCK cells on permeable filters were coimmu-
nostained for ASPP2 (C2; green), PAR-3 (magenta or red),
and E-cadherin (blue). The upper panels show correspond-
ing z sections of the lower panels, which show single
confocal x-y sections at the apical side. Arrowheads indicate
the positions of the corresponding x-y or z confocal
sections.
(F) Arrows indicate the colocalization of ASPP2 (green),
PAR-3 (red), and ZO-1 (blue) to apical cell-cell junctions in
columnar epithelial cells in mouse renal tubules. Arrowheads
indicate cell-cell junctions with higher ZO-1 signals than
ASPP2 or PAR-3 signals.
Scale bars represent 10 mm (C, E, and F).
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the interaction between ASPP2 and PAR-3, we examined the
cellular distribution of ASPP2, because the possible extranu-
clear functions of mammalian ASPP2 have not been investi-
gated, and its cellular distribution has not been determined.
Confocal microscopy using the two anti-ASPP2 antibodies,
C2 and C3, in MDCK cells demonstrated a reproducible
continuous linear signal in the apical region of the cell-cell
contacts (Figure 1C; Figure S3A). Importantly, these signals
were diminished by RNA interference (RNAi) for ASPP2,
whereas the expression levels of other proteins, including
PAR-3, were maintained (Figures 1C and 1D; Figure S3A). In
addition, exogenously expressed ASPP2 distributed to the
apical region of the cell-cell contacts (Figure S3C). Further-
more, ASPP2 selectively colocalized with PAR-3 and the TJ
protein zonula occludens 1 (ZO-1), whereas it was distributed
in a mutually exclusive manner with the lateral junction proteinE-cadherin (Figures 1C and 1E). These observa-
tions strongly support the notion that ASPP2 co-
localizes with PAR-3 to apical cell-cell junctions
in polarized MDCK cells. 293T cells also demon-
strated the colocalization of ASPP2 and PAR-3
at the cell-cell contact sites (Figure S3D).
The characteristic distribution of ASPP2 at
apical cell-cell junctions was also observed in
highly polarized columnar epithelial cells in mouse
tissues such as renal tubules and the smallintestine (Figure 1F; Figure S3E). The specificity of this staining
was confirmed by preabsorption of anti-ASPP2 antibody with
the corresponding antigen. Interestingly, the apical cell-cell
junctions of renal epithelial cells showed a variable concentra-
tion of ASPP2 and PAR-3 along the nephron. Some of these
cells showed a similar variation in the concentration of
ASPP2 and PAR-3, whereas that of ZO-1 was virtually
constant, suggesting a close relationship between the two
proteins (Figure 1F). These results confirm the colocalization
of ASPP2 and PAR-3 in polarized epithelial cells in vivo.
ASPP2 Is Involved in the Formation of Tight Junctions
The physical interaction and colocalization between ASPP2
and PAR-3 imply a close functional relationship. Thus, we
investigated whether ASPP2 is involved in the cell polarization
process, as reported for PAR-3, such as in the formation of TJs
and the development of the apical membrane domains [23, 24].
Figure 2. ASPP2 Is Required for the Efficient Formation of Tight Junctions
(A) The time course of tight junction (TJ) formation after calcium switch (CS)
was compared between NS and ASPP2-RNAi MDCK cells by immunostain-
ing for ZO-1 or occludin. Confluent MDCK cells cultured on permeable filters
were subjected to low calcium medium for 20 hr and observed at each time
point (0 to 24 hr) after the restoration of calcium, as indicated. Scale bars
represent 10 mm.
(B) The development of transepithelial electrical resistance (TER) was
compared between NS, ASPP2-RNAi, and PAR-3-RNAi MDCK cells by
measuring it at different times after CS. The error bars indicate the standard
deviation (SD; n = 3).
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1410First, we examined the role of ASPP2 in TJ formation. Depolar-
ized control or ASPP2-RNAi cells were supplied with calcium
(calcium switch, CS) to make cell-cell contacts, and TJ
formation was monitored by staining of the TJ proteins ZO-1
and occludin. Although the formation of TJs was accom-
plished within 6 hr in control cells, ASPP2-RNAi cells exhibited
a profound delay (Figure 2A). Twenty-four hours after CS,
however, there were no apparent differences between control
and ASPP2-RNAi cells. These properties of ASPP2-RNAi
cells are very similar to those of PAR-3-RNAi cells [23] and
suggest the involvement of ASPP2 in the formation of TJs.
This notion was further confirmed by a functional measure of
TJ integrity, transepithelial electrical resistance (TER) (Fig-
ure 2B) [25]. In control cells subjected to CS, the TER rose to
a peak 6–8 hr after CS as the junctions matured, followed by
a gradual decline. Such development of the TER was signifi-
cantly abolished in PAR-3-RNAi cells, as reported previously
[23], and in ASPP2-RNAi cells to a lesser extent. Taken
together, these results indicate that ASPP2 is involved in the
formation of TJs.
ASPP2 Is Involved in the Development and Maintenance
of Apical Domains
We next examined whether ASPP2 plays a role in the develop-
ment of apical membrane domains, as has been reported
for PAR-3 [24]. The formation of apical domains can be moni-
tored by the disappearance of the vacuolar apical compart-
ments (VACs) after CS. VACs represent endocytosed apical
membrane proteins that become apparent during depolariza-
tion by calcium depletion and are exocytosed to reform apical
domains after CS [26]. In control MDCK cells, gp135-positive
VACs induced by prolonged calcium depletion were observed
in 37% (319 of 859) of cells. CS quickly resulted in the relocal-
ization of gp135 from VACs to apical domains within 3 hr,
resulting in 9.5% (115 of 1205) of cells retaining VACs (Figures
3A and 3B), as reported previously [24]. In ASPP2-RNAi cells,
calcium depletion induced VACs at a similar level (40.9%,
409 of 1000 cells) to that of the control cells. However, the
relocalization of gp135 from VACs to apical domains after CS
was substantially delayed, with 24.3% (344 of 1418) of cells still
containing VACs after 3 hr (Figures 3A and 3B). These effects of
ASPP2-RNAi were further confirmed by transient transfection
with two independent small interfering RNAs (siRNAs) (Figures
S4A and S4B). These results indicate that ASPP2 is required
for the development of apical domains.
Another measure of epithelial cell polarity mediated by the
PAR complex is the recruitment of apical proteins to the cell
surface from the intracellular compartment during the mainte-
nance phase of cell polarity [22]. This phenomenon was clearly
demonstrated in MDCK cells in the absence of cell-cell contact
induced by low calcium conditions. Many control cells
retained apical proteins such as gp135 at the cell periphery
(nonsilencing, NS; Figure 3C). This apical domain retention
was significantly affected in PAR-3-RNAi cells [22] (Figure 3D).
Similarly, but to a lesser extent, ASPP2-RNAi cells failed to
retain apical domain proteins; gp135, ezrin, and F-actin failed
to distribute to the cell periphery and instead accumulated in
the intracellular regions (Figure 3C). The proportion of cells
retaining gp135 at the cell periphery was significantly lower
in ASPP2-RNAi cells (28% 6 6%, n = 3) than in control cells
(67% 6 2%, n = 3) (Figure 3D). Consistent results were
obtained by transient transfection with two independent
siRNAs against ASPP2 (Figure S4C). These data indicate that
ASPP2 is required for the maintenance of apical domains.ASPP2 Colocalizes with PAR-3 to Primordial Cell-Cell
Contacts
Physical interaction and an intimate functional relationship
between ASPP2 and PAR-3 suggest the importance of the
colocalization of ASPP2 and PAR-3 in the regulation of epithe-
lial cell polarity. We compared the distribution of ASPP2 and
PAR-3 during the polarization process. In polarized MDCK
cells, ASPP2 and the components of the PAR complex localize
to the apical junctions (Figures 1C and 1E) [20, 27]. On the other
hand, they move to different compartments in depolarized
cells: aPKC and PAR-6b move to VACs, whereas PAR-3
remains at the cell periphery (Figure 3F), although the exact
destination of PAR-3 has not been established [24]. Impor-
tantly, ASPP2 was not detected in VACs, but it distributed to
the cell periphery and to the remaining cell-cell contacts with
ZO-1 (Figures 3E and 3F), showing a sharp contrast to aPKC
and PAR-6. Note that nonspecific signals were possibly
observed following nuclear staining of ASPP2 under low
calcium conditions, because only the signals in cell-cell junc-
tions were diminished by RNAi against ASPP2 (Figure S3B).
Furthermore, ASPP2 and PAR-3 colocalized to the fragmen-
tally remaining cell-cell contacts labeled with ZO-1 in low
Figure 3. ASPP2 Is Required for the Development
and Maintenance of Apical Domains in MDCK
Cells
(A) The development of apical domains was
assessed 3 hr after CS in NS and ASPP2-RNAi
MDCK cells. The apical domains were labeled
with gp135, and the whole cell cortices, including
the vacuolar apical compartments (VACs), were
labeled for F-actin. Projected views of confocal
sections are presented with z sectional views.
ASPP2-RNAi cells contain large intracellular
aggregates positive for gp135 and F-actin, repre-
senting VACs, which indicate failure of appro-
priate apical domain development.
(B) The time courses of VAC exocytosis induced
by CS (time 0) were quantified for NS control (dia-
monds) and ASPP2-RNAi (circles) MDCK cells.
(C) Confluent monolayers of NS and ASPP2-RNAi
MDCK cells on permeable filters were subjected
to low calcium medium for more than 20 hr. The
retention of apical domains was analyzed by
labeling for gp135, F-actin, or ezrin, whereas the
disassembled cell-cell junctions were confirmed
by labeling for ZO-1 or F-actin. The representa-
tives from three independent experiments are
shown, and each photograph represents the pro-
jected views of confocal sections from the apical
to the basal membrane of cells. Arrows indicate
VACs.
(D) Quantification of the cells retaining apical
domains with peripheral gp135 staining, as indi-
cated in (C).PAR-3-RNAi cells served as a positive
control for the experimental procedures. The
percentage of the total cells (at least 460 cells)
is shown as the mean value (6SD) of three inde-
pendent experiments. The p values were deter-
mined by two-tailed Student’s t test.
(E) Confluent MDCK cells cultured on a permeable
filter were subjected to a low calcium medium for
20 hr. VACs are identified as large intracellular
structures strongly stained for gp135, a represen-
tative marker for apical domains (arrows). ASPP2
colocalizes with ZO-1 at the remaining cell-cell
contacts (arrowheads).
(F) MDCK cells cultured for more than 20 hr in low
calcium conditions were restored with 1.8 mM
Ca2+ for 30 min (CS 0.5 hr). The localization of
ASPP2 (green), PAR-3 (magenta), and ZO-1 is
demonstrated in projected views of optical
sections from the apical to the basal membranes
of cells. Proteins distributed at the cell periphery
and cell-cell contacts are indicated by arrows
and arrowheads, respectively.
Scale bars represent 10 mm (A, C, E, and F).
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during epithelial polarization shortly after restoring calcium
(Figure 3F). These observations strongly support the occur-
rence of the ASPP2-PAR-3 complex at primordial cell-cell
contacts before aPKC-PAR-6b is recruited to PAR-3 [24, 28].
ASPP2 Forms a Protein Complex with PAR-3
Independently of Lgl
The activity of the PAR-3-aPKC-PAR-6 complex is negatively
regulated by Lgl, which competes for the aPKC-PAR-6
complex with PAR-3 [22]. To evaluate the involvement of
ASPP2 in this process, we examined whether Lgl-1/2 affected
the interaction between ASPP2 and PAR-3. Depletion of Lgl-1/
2 clearly increased the amounts of aPKC and PAR-6b copreci-
pitated with PAR-3, confirming the enhanced association of
the aPKC-PAR6b complex with PAR-3 (Figure 4A) [22].However, depletion of Lgl-1/2 did not significantly affect the
amount of ASPP2 coprecipitated with PAR-3. Consistently,
depletion of Lgl-1/2 did not significantly increase the amount
of PAR-3 coprecipitated with ASPP2, whereas the levels of
aPKC and PAR-6b were increased. These results suggest
that the interaction between ASPP2 and PAR-3 is independent
of Lgl. Taken together with the colocalization of ASPP2 and
PAR-3 from the initial phase of polarization, our observations
support the intimate relationship between these proteins.
The Interaction between ASPP2 and PAR-3 Is Required
for Epithelial Cell Polarity
The close functional relationship and colocalization of ASPP2
and PAR-3 allowed us to examine the mutual relationship
between ASPP2 and PAR-3 in terms of their localization. We
found that the signals for ASPP2 in cell-cell junctions were
Figure 4. Interaction between ASPP2 and PAR-3 Is Required for Epithelial Cell Polarity
(A) NS and Lgl-1/2 double RNAi MDCK cells were subjected to immunoprecipitation with the indicated antibodies. Fractions of the cell lysate (input: NS,
0.3%, 0.2%, and 0.15%; Lgl-1/2-RNAi, 0.3%) and coprecipitated proteins (IP, 20% each) were analyzed by western blotting using antibodies against the
indicated proteins. Relative intensities are shown in numbers below the bands.
(B) ASPP2 (green), PAR-3 (magenta), and ZO-1 were localized in confluent monolayers of NS, PAR-3-RNAi, and ASPP2-RNAi MDCK cells. Single confocal
sections at the apical side demonstrate substantially diminished signals for ASPP2 (arrows) or PAR-3 (arrowheads) in the cell-cell junctions in PAR-3- or
ASPP2-RNAi cells, respectively. Instead, the signals for ZO-1 were not notably altered. Scale bar represents 10 mm.
(C) Quantification of the normalized signals for ASPP2 (top) or PAR-3 (bottom) in PAR-3- or ASPP2-RNAi cells, respectively. The signals were normalized
against ZO-1 staining, and the means of two independent experiments are shown.
(D) MDCK cells expressing or not expressing the N-terminal part of ASPP2 (ASPP2-N) were subjected to immunoprecipitation with the indicated antibodies.
Fractions of the cell lysate and coprecipitated proteins were analyzed by western blotting using the indicated antibodies.
(E) The localization of endogenous ASPP2 was analyzed in control and ASPP2-N-expressing MDCK cells. The signals for ASPP2 were substantially reduced
in ASPP2-N-expressing MDCK cells (arrows).
(F and G) The formation of TJs and apical domains after CS was compared between control and ASPP2-N-expressing MDCK cells by labeling for ZO-1 (F) or
F-actin (G). Arrows indicate incomplete formation of TJs (F) or remaining VACs (G).
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against either ASPP2 or PAR-3 did not apparently affect the
signals for ZO-1 in confluent MDCK cells (Figures 4B and 4C).
Similarly, the signals for PAR-3 were significantly reduced in
ASPP2-RNAi cells. Note that the expression level of ASPP2
was not affected in PAR-3-RNAi cells, and vice versa, in either
normal or low calcium conditions (Figure 1D). These results indi-
cate themutual dependence ofASPP2 and PAR-3 for their local-
ization at apical cell-cell junctions, further supporting the close
functional relationship between ASPP2 and the PAR complex.
To investigate the physiological significance of the interac-
tion between ASPP2 and PAR-3, we utilized overexpression
of the N-terminal part of ASPP2 (ASPP2-N; Figure S2E) to per-
turb this interaction. Immunoprecipitation analysis of MDCKcells expressing ASPP2-N revealed interference in the forma-
tion of the complex between endogenous ASPP2 and PAR-3
(Figure 4D). These cells demonstrated reduced localization
of endogenous ASPP2 at cell-cell junctions, suggesting that
the localization is dependent on the interaction with PAR-3
(Figure 4E). Importantly, these cells also showed delayed
formation of cell-cell junctions and apical domains after CS
(Figures 4F and 4G). These data demonstrate that the interac-
tion between ASPP2 and PAR-3 is important in the regulation
of epithelial cell polarity.
Conclusions
In this study, we provide evidence that ASPP2 plays critical
roles in the establishment and maintenance of epithelial
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through the regulation of PAR-3 localization. In addition to
epithelial polarity, the PAR complex has been shown to regu-
late asymmetric cell division [1, 13, 14]. Furthermore, a recent
report has shown that p53 regulates the polarity of self-renew-
ing division of mammary stem cells [29]. However, the molec-
ular mechanisms have not yet been elucidated. Considering
the role of ASPP as an important mediator of p53 [10, 12],
our data may shed light on a possible link between cell fate




MDCK II cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM; Nissui Pharmaceutical) containing 10% fetal calf serum (FCS), peni-
cillin, and streptomycin (BioWhittaker) at 37C in a 5% CO2 atmosphere at
constant humidity. For the Ca2+-depletion assay, cells were seeded on
Transwell filters (12 mm diameter, 0.4 mm pore size; Corning Coaster) at
2 3 105 cells/cm2 and grown for 1 or 2 days to produce a confluent mono-
layer. Cells were washed twice with phosphate-buffered saline and incu-
bated in a low Ca2+ (LC) medium containing 5% FCS, 3 mM Ca2+, penicillin,
and streptomycin for more than 20 hr. The Ca2+ switch assay was performed
by replacing the LC medium restored with 1.8 mM Ca2+.
Expression Vectors
For generating MDCK cells stably expressing SBP-tagged proteins under
the control of tetracycline-inducible transactivation, the SacI-PvuI fragment
of the pNTAP vector (Stratagene) was first cloned into the EcoRV and
PstI sites of the pOS-Tet14MCS vector (a generous gift from Y. Miwa,
Tsukuba University) after blunting, and then a cDNA encoding rat PAR-3
(1–1333 aa) [27] or mouse sPAR-3 (1–1034 aa) [21] was cloned into the
EcoRV site. cDNAs encoding rat PAR-3 (1–1333 aa) and human ASPP2
(2–1128 aa; IMAGE cDNA clone ID 4537206, GenBank ID Q13625) were
subcloned into the SR-HA and SR-V5 mammalian expression vectors,
respectively.
RNAi for ASPP2 in MDCK Cells
Nonsilencing control and ASPP2-RNAi MDCK clones were established by
stable transfection with pSUPERIOR.neo vectors (Oligoengine) encoding
a scramble sequence (50-CAGUCGCGUUUGCGACUGG-30; Dharmacon
Research) [22, 30] and the canine ASPP2 siRNA sequence (ASPP2-siRNA1,
#2315: 50-GCACUUCUCCACUGUUUAUGG-30), respectively. The PAR-3-
RNAi MDCK stable clone was described previously [22]. The sequences
of siRNAs used were nonsilencing control (QIAGEN Cat# 1027281), ASPP2-
siRNA1 (#2315), and ASPP2-siRNA2 (#3326: 50-GUUCCUCGUGCAAUUUG
GUGU-30). The ASPP2 siRNAs were designed to avoid any off-target effects
on ASPP1 or iASPP.
Immunoprecipitation and Western Blot Analysis
MDCK II and 293T cells were lysed in lysis buffer containing 50 mM Tris-HCl
at pH 7.5, 150 mM NaCl, 10% glycerol, 1% NP-40, 5 mM MgCl2, 1 mM EGTA,
1 mM dithiothreitol, protease inhibitor cocktail (SIGMA), and phosphatase
inhibitor cocktail (Roche). After centrifugation at 20,000 3 g for 30 min,
the supernatants were subjected to immunoprecipitation with the indicated
antibodies followed by SDS-PAGE and western blotting, as described
previously [22].
Antibodies
The rabbit anti-ASPP2 antibodies, C2AP and C3AP, were raised against aa
773–912 of human ASPP2 fused with glutathione-S-transferase and were
affinity purified (Scrum). Rat anti-PAR-3 polyclonal antibody (pAb) (CR1-
2AP) and rabbit anti-PAR-6b pAb (BC31AP) were described previously
[20, 24]. Antibodies purchased were rabbit anti-PAR-3 pAb (07-330;
Upstate), mouse anti-aPKCi monoclonal antibody (mAb; clone 23; BD
Transduction Laboratories), mouse anti-occludin mAb (clone OC-3F10;
Zymed), mouse anti-E-cadherin mAb (clone 36; BD Transduction Laborato-
ries), rabbit anti-aPKCz/l pAb (SC-216; Santa Cruz Biotechnology), rat
anti-ZO-1 mAb (clone R40.76; Santa Cruz Biotechnology), rabbit anti-14-
3-3b pAb (SC-629; Santa Cruz Biotechnology), mouse anti-ezrin mAb (clone
3C12; Sigma), and mouse anti-Lgl2 mAb (clone 4G2; Abnova). Mouse anti-gp135 mAb (clone 3F2/D8) was a gift from George K. Ojakian (State Univer-
sity of New York).
Immunofluorescence Microscopy
MDCK cells were fixed with 2% paraformaldehyde (PFA) and stained as
described previously [31]. The primary antibodies were visualized using
Alexa Fluor 488-, 555-, or 647-conjugated secondary antibodies (Molecular
Probes). Rhodamine-phalloidin was used to visualize filamentous actin
(Molecular Probes). Samples were mounted with ProLong Gold (Invitrogen)
and were observed using a confocal microscope system (LSM 510; Carl
Zeiss) or a fluorescence microscope (BX50; Olympus) equipped with
a cooled charge-coupled device camera (Sensys 1400G2; Photometrics).
Acquired images were analyzed using Photoshop (Adobe Systems), Multi
Gauge (Fujifilm), or ImageJ (National Institutes of Health), according to the
guidelines of the journal.
Mouse (ICR; Japan CLEA) kidneys and duodenum were perfused and
immersed in 0.1 M HEPES-NaOH buffer (pH 7.4) containing 4% PFA,
2.5 mM CaCl2, 1.25 mM MgCl2, and 2.9% glucose for 2 hr at room temper-
ature [32] and were processed for cryosectioning. The cryosections were
processed for heat-induced epitope retrieval by incubating in a target
retrieval solution (S1700; DAKO) for 15 min at 121C, and they were labeled
with anti-ASPP2 antibody (2.5 mg/ml, 16.7 nM) with 3.0 nM of the corre-
sponding antigen or GST. All animal experiments were conducted in accor-
dance with the Guidelines for Proper Conduct of Animal Experiments
(Science Council of Japan), and all protocols were approved by our institu-
tional review boards.
Supplemental Information
Supplemental Information includes four figures and can be found with this
article online at doi:10.1016/j.cub.2010.06.024.
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